Skip to main content
All Posts By

Enveric

May 11 2022
Love0

NASDAQ-Listed Enveric To Split Into Two Companies, One For Cannabinoids, One For Psychedelics

https://www.benzinga.com/markets/cannabis/22/05/27124788/exclusive-nasdaq-listed-enveric-to-split-into-two-companies-one-for-cannabinoids-one-for-psyched
Apr 19 2022
Love0

Enveric Offers Investors Rare Exposure To Both Cannabis And Psychedelic Industries [Benzinga]

https://www.benzinga.com/general/biotech/22/04/26693851/exclusive-enveric-offers-investors-rare-exposure-to-both-cannabis-and-psychedelic-industries
Mar 29 2022
Love0

Inside the Race to Make Psychedelics ‘Mainstream Medicines’ [NXT Psychedelics]

https://www.nxtpsychedelics.com/news/articles/psychedelics/inside-the-race-to-make-psychedelics-mainstream-medicines/
Mar 24 2022
Love0

Five Companies Developing Second Generation Psychedelics For Mental Health [Benzinga]

https://www.benzinga.com/markets/cannabis/22/03/26284541/five-companies-developing-second-generation-psychedelics-for-mental-health
Feb 21 2022
Love0

Groundbreaking Trial to Explore Psychedelic Therapy for Cancer Distress [Psychedelic Health]

https://psychedelichealth.co.uk/2022/02/21/trial-psychedelic-therapy-cancer-distress/
Feb 17 2022
Love0

UCalgary to Collaborate on Clinical Trial Assessing Psychedelic Treatments and Cancer Related Distress [The Edmonton Journal]

https://edmontonjournal.com/cannabis-health/ucalgary-to-collaborate-on-clinical-trial-assessing-psychedelic-treatments-and-cancer-related-distress

© 2022 Enveric Biosciences | Terms of Use | Privacy Policy

Enveric Biosciences is a development stage company that markets no products at this time. The content of this site is not intended to be promotional or to suggest any product or use of a product that has been approved by any regulatory body.